D. Maxwell

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

C. Moore, I. James, F. Christiansen, 2002, The Lancet.

Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series

Patrick R. Ching, K. Dooley, P. Sax, 2022, AIDS Research and Therapy.

The Clinical Utility of the Concept of Jing in Chinese Reproductive Medicine

D. Maxwell, 2012 .

COVID-19 therapeutics for low- and middle-income countries: a review of re-purposed candidate agents with potential for near-term use and impact

A. Olotu, A. Hachem, O. Sabot, 2021, medRxiv.

Rates of combination antiretroviral treatment change in Australia, 1997–2000

C. Moore, S. Mallal, D. Cooper, 2002 .

HLA-DQ 3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

C. Moore, I. James, C. Witt, 2022 .

Notes from the Field: Zoonotic Mycobacterium bovis Disease in Deer Hunters — Michigan, 2002–2017

D. Maxwell, S. Robbe-Austerman, Jennifer L. Sidge, 2019, MMWR. Morbidity and mortality weekly report.

“The Art of War” in the Era of Coronavirus Disease 2019 (COVID-19)

T. Perl, D. Maxwell, J. Cutrell, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

COVID-19 Therapeutics for Low- and Middle-Income Countries: A Review of Candidate Agents with Potential for Near-Term Use and Impact

A. Olotu, A. Llanos-Cuentas, O. Sabot, 2021, The American journal of tropical medicine and hygiene.